CHI Logo
Loading...

 

Conference Menu

Overview
Short Courses 
Register
Hotel & Travel
Participant List 
PDF Download
Sponsor / Exhibit
Posters
Press Pass 
Request Brochure
Archive 

Join our LinkedIn Group
LinkedIn

Lead Sponsoring Publications

American Pharmaceutical Review - APR

Bio-IT-Word_logo

BioPharm

Gen

International_drug_disc

Nature_logo

Science AAAS logo

The Scientist

 

Sponsoring Publications

DrugDiscoveryNews

Pharma Services News

PharmaVoice

Web Partners

Biospace

Pharm Cast

Baculovirus Technology


Loading...

 

Baculovirus Technology Banner

Baculovirus vectors are widely used as tools for expressing proteins, delivering genes into cells, and creating vaccines. Once viewed as an alternative, the baculovirus system has achieved recognition through extensive clinical testing and regulatory exposure. The speed of reaching protein expression and the inability to transmit mammalian disease makes baculovirus an attractive platform.

The Baculovirus Technology meeting brings together experts who are innovating applications and achieving clinical success. Along with seminal insights into biological properties, case studies from industry leaders will address breakthrough approaches to increasing protein expression levels and humanizing the N-glycosylation pathway. Come explore the intricacies and successes of Baculovirus Technology.


Preliminary Agenda


BIOLOGICAL PROPERTIES

Opening Keynote Presentation: Strategies for Baculovirus Replicative Success: Viral Induction and Inhibition of Apoptosis

Paul Friesen, Ph.D., Professor, Biochemistry & Institute for Molecular Virology, University of Wisconsin-Madison

The Baculovirus Expression Platform: Recent Advances and More Lessons Learned

James Groarke, Ph.D., Fellow, DT Protein Stucture, Novartis Institutes for BioMedical Research, Inc.

Insights into Baculovirus Entry and a New Highly Productive Insect Cell Line

Gary Blissard, Ph.D., Adjunct Professor, Department of Microbiology & Immunology, and Department of Entomology,
Cornell University



VACCINE DEVELOPMENT

Using a Novel Glyco-Engineered Insect Cell Line to Examine the Role of Glycan Structure in Influenza Virus Subunit Vaccine Efficacy

Donald Jarvis, Ph.D., Professor, Molecular Biology, University of Wyoming

Utilizing the BEVS to Explore the Natural Immunity of Mosquitoes to Malaria

Richard Baxter, Ph.D., Howard Hughes Medical Institute & Laboratory of Professor Johann Deisenhofer, University of Texas Southwestern Medical Center

Talk Title to be Announced

Indresh Srivastava, Ph.D., Associate Director, Vaccines Research, Protein Biochemistry, Novartis Vaccines & Diagnostics Inc.



PROTEIN EXPRESSION

The MultiBac System: New Baculovirus Expression Tools for Multiprotein Complex Production

Imre Berger, Ph.D., Group Leader, Structural Biology Unit, EMBL Grenoble

Efficient Protein Expression in Bombyx mori Larvae of the Strains Highly Sensitive to B. mori Nucleopolyhedrovirus

Takahiro Kusakabe, Ph.D., Associate Professor, Applied Genetics and Pest Management, Kyushu University Graduate School



SCREENING

High-Throughput Methodology for the Rapid Screening of Gene Targets in a Baculovirus Platform

Jared Cartwright, Ph.D., Head, Protein Production Laboratory, Biology, University of York


By Series:
By Region:

Loading...

2010 Conference
& Course Catalog

CHI Catalog